Levi's Earnings Lift Leaves a Direct-Sales Test

Separate the profit lift from the demand test

Levi Strauss's October 7 results leave investors with two different questions: how much of the earnings improvement is repeatable, and is the direct-to-consumer business regaining momentum? For the quarter ended August 30, reported revenue rose 4% and organic revenue rose 5%. Continuing-operations diluted EPS was $0.43; adjusted diluted EPS was $0.48.

The company identified a $0.11 net EPS benefit from tariff refunds after reinvestment in the business. Its revised full-year adjusted EPS outlook is $1.54–$1.56. Those disclosures argue for a bridge between the reported profit improvement and the assumptions used for future earnings.

A refund can improve this period's economics without establishing that the next period's sales will accelerate. Conversely, spending some of that benefit on the business can support later demand without proving that the investment has already worked. A useful model keeps the benefit, the spending and the expected operating response on separate lines. Combining them into one recurring growth rate makes it harder to test what actually changed.

The direct channel needs its own scorecard

Third-quarter DTC revenue increased 2% on both reported and organic bases, while wholesale rose 6% on both measures. The detailed table puts DTC comparable sales growth at 0.4%; the release describes it as flat. Management says DTC missed its internal expectations and anticipates mid-single-digit DTC growth in the fourth quarter.

The July 8 second-quarter report provides a useful comparison: DTC revenue grew 11% as reported and 8% organically, with comparable sales up 6%. Those figures refer to the quarter ended May 31, not the latest period. They show why the overall company growth rate is insufficient to judge progress in its direct channel.

Compare like with like. Total channel revenue, comparable sales and organic growth answer related but different questions. A store opening can affect total sales without showing the same result in a comparable-store measure; currency translation can change reported growth without an equivalent change in local demand. The research task is to understand which measure supports the investment thesis, then follow that measure consistently.

Do not compare successive quarters as though they were the same selling season. Each year-over-year growth rate also has its own prior-year denominator. The change in reported growth is a reason to investigate the operating explanation, not a complete explanation on its own.

Use last year to check the comparison base

Levi's third-quarter 2025 report showed DTC revenue growth of 11% reported and 9% organic, alongside high-single-digit comparable sales growth. DTC represented 46% of that quarter's revenue. The older report also recorded adjusted EBIT margin of 11.8%, versus 12.3% a year earlier, as higher SG&A weighed on the comparison.

That history is useful because it prevents two shortcuts. A strong sales comparison can make a later growth rate harder to sustain, but it does not automatically excuse any slowdown. And stronger sales do not guarantee stronger operating margins: the cost of generating and fulfilling those sales matters.

For the next update, build a compact comparison sheet with channel growth, comparable sales, gross margin and operating expenses. Keep the original reporting periods attached to every number. Add a separate note for unusual benefits and management's deployment of those benefits. This creates a way to distinguish a genuine improvement in customer demand from a favorable earnings comparison.

Avoid treating adjusted EPS as an automatically normalized measure. The label describes the company's chosen adjustments; it does not mean every unusual economic item has been removed. An investor's own sensitivity calculation should be labeled as analysis, with its assumptions visible, rather than presented as another company-reported result.

What would strengthen the recovery case

The most useful confirmation would be a subsequent operating update showing better direct-channel sales alongside acceptable profitability, with the sources of improvement explained. A more convincing recovery would not require readers to infer demand solely from the headline EPS number.

The countercase is that sales require heavier promotional support or that gains in one channel obscure weakness in another. These are scenarios to test, not claims that they have already occurred. Watch whether the next disclosures separate pricing, demand, selling costs and exceptional benefits clearly enough to assess the trade-off.

The decision for a research model is therefore not simply whether to raise or lower one earnings estimate. It is which inputs deserve to recur. Keep the refund benefit tied to the period disclosed, treat the direct-sales recovery as an expectation until verified, and revise the operating assumptions when subsequent evidence supports them.